Imidazopyridines Syk inhibitors
US10842803B2 · kind B2 · utility
3Cited by
35References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2018 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Sep 6, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain imidazopyridines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.